Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

Healthcare AI today: 95% fail rate, epic at Epic, AI to the rescue of short staffs, more
Most organizations trying out generative AI—a full 95%—are failing to receive a measurable return on the pilot investment.
Johns Hopkins researchers: Time is running out to leverage AI for patients beyond a certain age
If three sticking points aren’t unstuck soon, older Americans won’t benefit much by the 1,000+ medical devices that, as of 2025, are both equipped with AI and cleared by the FDA.
Healthcare AI today: Cancer research rethought, Trump/Kennedy healthcare AI, ‘What’s best for the patient?’
A new generation of AI-native researchers is leading the way in the war on cancer. This next crop of scientists is AI-native, interdisciplinary—and comfortable challenging assumptions.
Medical researchers: ‘Doctors must be the leaders in the digital evolution of medicine.’
The roots of medicine are in the promotion of human welfare, aka humanitarianism. Healthcare AI can either degrade or reinforce this heritage. Who picks the path?
New hypertension guidelines embrace early treatment, updated risk assessments and renal denervation
New ACC/AHA recommendations encourage clinicians to take a proactive approach when managing patients with elevated or high blood pressure. The inclusion of renal denervation in this document represents clear progress for a relatively new technology.

IV hospital room intravenous drip solution

Industry Watcher’s Digest

The FDA has finalized its recommendations for getting AI-equipped medical devices approved.

artificial intelligence AI in healthcare

Providers, payers share actionable experiences involving healthcare AI

A large venture capital firm focused on supporting early-stage healthtech companies has a tip for AI startups targeting the healthcare sector.

Robotic aortic valve replacement (RAVR) is a new minimally invasive treatment option for symptomatic severe aortic stenosis (AS) that uses advanced robotic surgical systems. It has already started gaining momentum as an alternative to both surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR).

Q&A: Pioneer heart surgeon on the development and long-term potential of robotic aortic valve replacement

It's early for RAVR, but the minimally invasive technique has already started gaining momentum as an alternative to both SAVR and TAVR. We spoke to Vinay Badhwar, MD, one of the world’s leading voices in robotic heart surgery, to learn more.

Heart surgeons with the WVU Heart and Vascular Institute have made a bit of history, performing the world’s first combined robotic aortic valve replacement (AVR) and coronary artery bypass grafting (CABG) procedure—all through one small incision. Patients requiring these procedures typically undergo open-heart surgery.

Heart surgeons perform world’s first combined robotic AVR and CABG

The entire robotic procedure was performed through one small incision. Surgeons originally recommended the 73-year-old patient undergo open-heart surgery, but she requested a less invasive alternative.

Off-label TAVR for native aortic regurgitation linked to worse outcomes

Targeting aortic regurgitation with TAVR valves built to treat aortic stenosis may be the only option a cardiologist has—but valves designed specifically to treat AR are linked to much better outcomes, according to a new meta-analysis. Edwards Lifesciences recently acquired the two companies at the center of this study, JenaValve and JC Medical.

Industry Watcher’s Digest

Federal AI guardrails are taking shape.

Healthcare-specific AI: How to multiply successes and head off accidents

Given the rapid proliferation of AI-equipped medical devices across U.S. healthcare, unintended effects should surprise no one.

Newsweek ranked the 50 best heart hospitals in the world

Prosthesis-patient mismatch after TAVR: 5 key findings related to patients with small annuli

PPM is still relatively common after TAVR, especially among patients with a small aortic annulus. What can be done to minimize the risk of PPM? Does valve type play a role? Researchers explored those questions, and many others.

Care Delivery

Healthcare AI today: 95% fail rate, epic at Epic, AI to the rescue of short staffs, more

Johns Hopkins researchers: Time is running out to leverage AI for patients beyond a certain age

Healthcare AI today: Cancer research rethought, Trump/Kennedy healthcare AI, ‘What’s best for the patient?’

Medical researchers: ‘Doctors must be the leaders in the digital evolution of medicine.’

New hypertension guidelines embrace early treatment, updated risk assessments and renal denervation